MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2013.11.072

Медицинская библиотека · Journal of the American College of Cardiology · 2014

Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Patton Kristen K, Hellkamp Anne S, Lee Kerry L, Mark Daniel B, Johnson George W, Anderson Jill, Bardy Gust H, Poole Jeanne E, SCD-HeFT Investigators

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

This study sought to determine whether circadian patterns in ventricular arrhythmias (VAs) occur in a current primary prevention defibrillator (implantable cardioverter-defibrillator [ICD]) population.

BACKGROUND

Cardiovascular events, including VAs, demonstrate biorhythmic periodicity.

METHODS

We tested for deviation from the previously described occurrences of a morning peak, early morning nadir, and peak on Mondays in ICD therapies using generalized estimating equations and Student t tests. All hypothesis tests were performed in the entire cohort of patients with VAs as well as pre-specified subgroups.

RESULTS

Of 811 patients with an ICD, 186 subjects experienced 714 ICD therapy episodes for life-threatening VA. There was no morning (6 am to 12 pm) peak in therapies for the entire cohort or any subgroups. The overall cohort and several subgroups had a typical early morning (12 am to 6 am) nadir in therapies, with significantly less than 25% of therapies occurring during this 6-h block (all p < 0.05). A significant peak in therapies on Mondays occurred only in patients not on beta-blocker therapy (22% of events for the week, p = 0.029).

CONCLUSIONS

In the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) population, the distribution of life-threatening VA failed to show a typical early morning peak or increased VA events on Mondays. A typical early morning nadir was seen in the entire cohort. An increased rate of events on Mondays was found in the subgroup of subjects not on beta-blocker therapy. These findings may indicate suppression of the neurohormonal triggers for VA by current heart failure therapy, particularly the use of beta-blockers in heart failure.

Для цитирования: Patton Kristen K, Hellkamp Anne S, Lee Kerry L, Mark Daniel B, Johnson George W, Anderson Jill, Bardy Gust H, Poole Jeanne E, SCD-HeFT Investigators. Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).. Journal of the American College of Cardiology. 2014. DOI: 10.1016/j.jacc.2013.11.072.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.